Formulations:
- Oral > Solid: 25 mg tablet
Parenteral > General injections > unspecified: 500 mg in vial powder for injection
Parenteral > General injections > IV: 500 mg in vial powder for injection; 1 g in vial powder for injection; 2 g in vial powder for injection
Oral > Solid > dosage form: 25 mg; 50 mg
Indications:
- Unspecified malignant neoplasms of ill-defined or unspecified sites
- Other specified malignant neoplasms of breast
- Follicular lymphoma
- Malignant trophoblastic neoplasms of placenta
- Malignant neoplasms of breast
- Diffuse large B-cell lymphoma, not otherwise specified
- Chronic lymphocytic leukaemia or small lymphocytic lymphoma
- Hodgkin lymphoma
- Plasma cell myeloma
- Other specified gliomas of brain
- Burkitt lymphoma including Burkitt leukaemia
- Ewing sarcoma of bone and articular cartilage of unspecified sites
- Malignant neoplasms of kidney, except renal pelvis
- Lymphoid leukaemia, not elsewhere classified
- Anaplastic large cell lymphoma, ALK-negative
- Anaplastic large cell lymphoma, ALK-positive
- Rhabdomyosarcoma primary site
Source: EML workbook import
Product metadata will be available once the catalog entry is complete.
Formulations:
- Oral > Solid: 25 mg tablet
Parenteral > General injections > unspecified: 500 mg in vial powder for injection
Parenteral > General injections > IV: 500 mg in vial powder for injection; 1 g in vial powder for injection; 2 g in vial powder for injection
Oral > Solid > dosage form: 25 mg; 50 mg
Indications:
- Unspecified malignant neoplasms of ill-defined or unspecified sites
- Other specified malignant neoplasms of breast
- Follicular lymphoma
- Malignant trophoblastic neoplasms of placenta
- Malignant neoplasms of breast
- Diffuse large B-cell lymphoma, not otherwise specified
- Chronic lymphocytic leukaemia or small lymphocytic lymphoma
- Hodgkin lymphoma
- Plasma cell myeloma
- Other specified gliomas of brain
- Burkitt lymphoma including Burkitt leukaemia
- Ewing sarcoma of bone and articular cartilage of unspecified sites
- Malignant neoplasms of kidney, except renal pelvis
- Lymphoid leukaemia, not elsewhere classified
- Anaplastic large cell lymphoma, ALK-negative
- Anaplastic large cell lymphoma, ALK-positive
- Rhabdomyosarcoma primary site
Source: EML workbook import